Simon Sturge Insider Profile

4 Followers
Simon Sturge, Director at MoonLake Immunotherapeutics, holds 171.98K shares in MoonLake Immunotherapeutics (Ticker: MLTX). Most recently, Simon Sturge Sold $171,000 shares of MoonLake Immunotherapeutics on Oct 08, 2024 for an estimated value of 9.19M.
tipranks
Simon Sturge

Simon Sturge
MoonLake Immunotherapeutics (MLTX)
Director

Not Ranked
Simon Sturge has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$8M
100.00%
A breakdown of Simon Sturge's holdings

Insider Roles

MoonLake Immunotherapeutics
(MLTX)
Director
Roles that Simon Sturge holds in companies

Most Profitable Insider Trade

Stock:
MoonLake Immunotherapeutics
(MLTX)
Rating:Informative Sell
Date:Oct 08, 2024 - Today
Return:+6.10%
The most profitable trade made by Simon Sturge

Simon Sturge's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MoonLake Immunotherapeutics
Oct 08, 2024
Director
Informative Sell
9.19M
$8.04M
Success Rate for
MLTX
1 out of 1 profitable transactions on
MLTX
100%
Average Return for
MLTX
Average return per transaction on
MLTX
+6.10%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 03, 2023
Uninformative Buy
$0.00
-
$0.00
Oct 03, 2023
Uninformative Sell
$0.00
-
$0.00
Oct 08, 2024
Informative Sell
$9.19M
-
$53.72
+6.10%
List of latest transactions for each holding click on a transaction to see Simon Sturge's performance on stock

Simon Sturge insider profile FAQ

What is the percentage of profitable transactions made by Simon Sturge?
The percentage of profitable transactions made by Simon Sturge is ―.
    What is the average return per transaction made by Simon Sturge?
    The average return per transaction made by Simon Sturge is ―.
      What stocks does Simon Sturge hold?
      Simon Sturge holds: MLTX stocks.
        What was Simon Sturge’s latest transaction?
        Simon Sturge latest transaction was an Informative Sell of $9.19M.
          What was Simon Sturge's most profitable transaction?
          Simon Sturge’s most profitable transaction was an Informative Sell of MLTX stock on October 8, 2024. The return on the trade was 6.10%.
            What is Simon Sturge's role in MoonLake Immunotherapeutics?
            Simon Sturge's role in MoonLake Immunotherapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.